Madopar HBS

Medicinal product

(Invented) name

Madopar HBS

Active substance (s)

Levodopa/Benserazidas

Strength

100 mg/25 mg

Pharmaceutical form

pailginto atpalaidavimo kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BA02, Levodopa and decarboxylase inhibitor

Marketing authorisation holder

UAB Roche Lietuva, Lietuva

Date of authorisation

1997-02-11

Date of renewal

2007-11-30

Documents

0936 Madopar, Madopar HBS RPP 2024 04 03.docx

0936 Pakuotės lapelis 2024 04 03.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Levodopa	100 mg
Benserazidas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
3740	1215	1001215	buteliukas	N100		Receptinis	LT/1/94/0936/004	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2007-11-30	Perregistruotas
1997-02-11	Registruotas